Patents by Inventor Benjamin Isaac Rapoport

Benjamin Isaac Rapoport has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250082414
    Abstract: Systems and methods for high-bandwidth, minimally invasive brain-computer interfaces (BCIs) are disclosed. The BCIs are configured for deployment and operation in conjunction with a comprehensive interventional electrophysiology procedural suite. Three primary methods of minimally invasive electrode array delivery are disclosed: (1) cortical surface delivery, (2) ventricular delivery, and (3) endovascular delivery. Additionally, systems and methods for interacting with such high-bandwidth electrode arrays are discussed, including real-time imaging, signal processing, and neural decoding. Systems and methods for architectures for accelerating the underlying computational processes (such as graphics processing units or tensor processing units) are also discussed. Multiple applications of BCIs are discussed, with emphasis on restoration, rehabilitation, and augmentation of neurologic function.
    Type: Application
    Filed: November 22, 2024
    Publication date: March 13, 2025
    Applicant: PRECISION NEUROSCIENCE CORPORATION
    Inventors: Benjamin Isaac RAPOPORT, Demetrios Philip Papageorgiou, Mark James Hettick
  • Publication number: 20250018084
    Abstract: A kit is provided for delivering local radiation to a tumor while also causing tumor devascularization. The kit includes a first liquid radioembolic agent for treatment of at least a first region of the tumor and a second liquid radioembolic agent for treatment of at least a second region of the tumor. The first liquid radioembolic agent includes: a biocompatible polymer or prepolymer and a first radioisotope having a first type of ionizing radiation for treatment of the first region of the tumor. The second liquid radioembolic agent includes: a biocompatible polymer or prepolymer and a second radioisotope having a second type of ionizing radiation for treatment of the second region of the tumor. The second type of ionizing radiation is different than the first type of ionizing radiation.
    Type: Application
    Filed: November 14, 2022
    Publication date: January 16, 2025
    Applicant: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
    Inventors: Alejandro BERENSTEIN, Benjamin Isaac RAPOPORT, Munir V. GHESANI, Joshua B. BEDERSON
  • Publication number: 20230000564
    Abstract: Systems and methods for high-bandwidth, minimally invasive brain-computer interfaces (BCIs) are disclosed. The BCIs are configured for deployment and operation in conjunction with a comprehensive interventional electrophysiology procedural suite. Three primary methods of minimally invasive electrode array delivery are disclosed: (1) cortical surface delivery, (2) ventricular delivery, and (3) endovascular delivery. Additionally, systems and methods for interacting with such high-bandwidth electrode arrays are discussed, including real-time imaging, signal processing, and neural decoding. Systems and methods for architectures for accelerating the underlying computational processes (such as graphics processing units or tensor processing units) are also discussed. Multiple applications of BCIs are discussed, with emphasis on restoration, rehabilitation, and augmentation of neurologic function.
    Type: Application
    Filed: July 5, 2022
    Publication date: January 5, 2023
    Applicant: PRECISION NEUROSCIENCE, LLC
    Inventors: Benjamin Isaac RAPOPORT, Demetrios Philip PAPAGEORGIOU, Mark James HETTICK
  • Patent number: 10297835
    Abstract: A glucose fuel cell for reception into a given constrained volume of implantation in a vertebrate in which the glucose fuel cell has access to fluid containing glucose. The fuel cell includes an anode adapted to oxidize the glucose, a cathode adapted to reduce an oxidant, and a membrane disposed between the anode and the cathode and separating the anode from the cathode. At least one of the anode or cathode define a flexible sheet that is geometrically deformed to be receivable into the given constrained volume of implantation and increase volumetric power density. Related methods of making a glucose fuel cell of this type and implantable assemblies including the glucose fuel cell are also disclosed.
    Type: Grant
    Filed: May 15, 2014
    Date of Patent: May 21, 2019
    Assignee: Massachusetts Institute of Technology
    Inventors: Rahul Sarpeshkar, Jeremy Bert Muldavin, Todd Addison Thorsen, Jakub Kedzierski, Benjamin Isaac Rapoport, Michale Sean Fee
  • Publication number: 20140342247
    Abstract: A glucose fuel cell for reception into a given constrained volume of implantation in a vertebrate in which the glucose fuel cell has access to fluid containing glucose. The fuel cell includes an anode adapted to oxidize the glucose, a cathode adapted to reduce an oxidant, and a membrane disposed between the anode and the cathode and separating the anode from the cathode. At least one of the anode or cathode define a flexible sheet that is geometrically deformed to be receivable into the given constrained volume of implantation and increase volumetric power density. Related methods of making a glucose fuel cell of this type and implantable assemblies including the glucose fuel cell are also disclosed.
    Type: Application
    Filed: May 15, 2014
    Publication date: November 20, 2014
    Inventors: Rahul Sarpeshkar, Jeremy Bert Muldavin, Todd Addison Thorsen, Jakub Kedzierski, Benjamin Isaac Rapoport, Michale Sean Fee